Related Experiment Video
Updated: Feb 16, 2026
Immunohistochemistry Test for the Lyssavirus Antigen Detection from Formalin-Fixed Tissues
Published on: October 26, 2021
Current methods in multiplex immunohistochemistry for formalin-fixed tissue samples
Insights
Multiplex immunohistochemistry (mIHC) advances spatial analysis of tumor microenvironments, overcoming limitations of traditional methods. Further integration into diagnostics requires standardization for improved cancer characterization and therapy.
Area of Science:
- Pathology
- Immunohistochemistry
- Cancer Research
Background:
- Traditional histopathology methods like H&E staining and chromogenic IHC have limitations in detecting multiple biomarkers and analyzing spatial cell relationships.
- Multiplex immunohistochemistry (mIHC) overcomes these limitations by enabling simultaneous detection of multiple epitopes and detailed spatial analysis in FFPE tissues.
- Characterizing tumor microenvironments is crucial for developing immunotherapies that have transformed cancer treatment.
Purpose of the Study:
- To review the capabilities of multiplex immunohistochemistry (mIHC) methods for analyzing formalin-fixed paraffin-embedded (FFPE) tissues.
- To discuss advancements in mIHC detection techniques, including chromogenic, immunofluorescence, nucleotide-conjugated antibodies, and mass spectrometry.
- To highlight the challenges and future prospects of integrating mIHC into routine clinical diagnostics.
Main Methods:
- Review of modern multiplex immunohistochemistry (mIHC) techniques.
- Discussion of various detection strategies: sequential cyclic labeling, tyramine signal amplification, nucleotide-conjugated antibodies, and mass spectrometry.
- Analysis of challenges including standardization, antibody validation, data analysis, and regulatory aspects.
Main Results:
- mIHC allows simultaneous detection of multiple biomarkers and spatial analysis of cell populations within the tumor microenvironment.
- Advanced techniques like nucleotide-conjugated antibodies and mass spectrometry offer enhanced specificity, quantitative analysis, and extensive biomarker profiling.
- Despite technological progress, routine clinical integration faces hurdles in standardization, validation, data analysis, and regulation.
Conclusions:
- Multiplex immunohistochemistry (mIHC) offers significant advantages over traditional methods for detailed tumor microenvironment analysis.
- Continued automation and digitization in pathology are expected to drive wider adoption of mIHC in clinical practice.
- Successful integration of mIHC promises deeper tumor characterization and improved patient therapy outcomes.
Abstract:
Traditional histopathological methods, such as hematoxylin and eosin staining and chromogenic immunohistochemistry, are still primarily used in clinical practice, however, they are limited in their ability to simultaneously detect multiple biomarkers and analyze spatial relationships between cell populations. These limitations are overcome by multiplex immunohistochemistry (mIHC) methods that allow detailed spatial analysis of formalin-fixed paraffin-embedded tissues with detection of multiple epitopes in a single sample. Detailed characterization of immune cell populations within tumor microenvironment has significantly contributed to the development of immunotherapeutic approaches, which have fundamentally transformed the prognosis of many advanced malignancies. Modern multiplex methods use both chromogenic and immunofluorescence detection and include sequential cyclic labeling or tyramine signal amplification techniques. Alternative approaches, such as the use of nucleotide-conjugated antibodies, allow highly specific detection and facilitate quantitative analysis, while mass spectrometry-based approaches enable the profiling of extensive biomarker panels. Despite significant technological advances, the integration of mIHC into routine clinical diagnostics remains challenging, primarily due to the need for standardization, antibody validation, advanced image data analysis integration, and the regulation of laboratory-developed tests. With the continued automation and digitization of pathology, wider use of mIHC in clinical practice can be expected, which could significantly contribute to the deeper characterization of tumors and improved therapy.
Related Concept Videos
01:18Sampling Methods: Sample Types
Solid samples include a variety of substances, such as sediments from water bodies, soil, metals, and biological tissues. Two standard methods for extracting sediments from water bodies are grab sampling and piston coring. Grab sampling involves using a device to collect a discrete sediment sample from the bottom of a water body with minimal disturbance. Grab samples do not always represent the entire area due to...
00:55Convenience Sampling Method
Convenience sampling is a non-random method of sample selection; this method selects individuals that are easily accessible and may result in biased data. For example, a marketing...
01:06Sampling Methods: Overview
In analytical chemistry, the choice of...
01:17Systematic Sampling Method
Systematic sampling is one of the simplest methods...
01:16Stratified Sampling Method
To choose a stratified sample, divide the population into groups called strata and then take a...
01:20Cluster Sampling Method
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...